𝔖 Bobbio Scriptorium

✦ LIBER ✦

142 Antiherpesvirus activity of BRL 44385 (9-(3-hydroxypropoxy)guanine) in animals: D. Sutton, R.J. Ashton, T.H. Bacon and M.R. Boyd. SmithKline Beecham Pharmaceuticals, Epsom, Surrey, UK

Book ID: 118393211
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 72 KB
Volume: 20
Category: Article
ISSN: 0166-3542
DOI: 10.1016/0166-3542(93)90520-s

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

69 Activity of famciclovir and penciclov

69 Activity of famciclovir and penciclovir in HSV-infected animals: A review: D. Sutton, R.J. Ashton, T.H. Bacon, and M.R. Boyd. SmithKline Beecham Pharmaceuticals, Epsom, Surrey, UK

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 78 KB

BRL 44385: Selective anti-herpesvirus ac

BRL 44385: Selective anti-herpesvirus activity and mode of action : A. G. Brown, T. H. Bacon, M. R. Boyd, S. J. Darlison, K. Martin, D. Sutton and R. A. Vere Hodge. SmithKline Beecham Pharmaceuticals, Epsom, Surrey, United Kingdom

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Selection of the acetal 2-amino-9-[3-(is

Selection of the acetal 2-amino-9-[3-(isopropoxymethoxy)propoxy]purine (BRL 55792) as an oral prodrug of the anti-herpesvirus agent 9-(3-hydroxypropoxy)guanine (BRL 44385) : M.R. Harnden, R. Ashton, M.R. Boyd, L.J. Jennings and D. Sutton, SmithKline Beecham Pharmaceuticals, Great Burgh, Epsom, Surrey KT18 5XQ, U.K.

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Activity of penciclovir and acyclovir in

Activity of penciclovir and acyclovir in DBA/2 mice infected intraperitoneally with HSV-1 (SC16) : M.R. Boyd, D. Sutton, and R.J. Ashton, SmithKline Beecham Pharmaceuticals, Epsom, Surrey, UK, KT18 5XQ

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 78 KB

75 Activity of BRL47923 and its oral pro

75 Activity of BRL47923 and its oral prodrug, SB203657A against a rauscher murine leukaemia virus infection in mice: R.M.Perkins1, S.Barney1, R.Wittrock1, P.H.Clark1, R.Levin1, D.M.Lambert1, S.R. Petteway1, H.Serafinowska2, S.Bailey2, S.M.Jackson2, M.R.Harnden2, R.J.Ashton2, D.Sutton2, J.J.Harvey3, A.G.Brown2. SmithKline Beecham Pharmaceuticals, King of Prussia, USA1, and Epsom, UK2. Clinical Research Centre, Harrow, UK3

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 68 KB